Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
drugs
May 22, 2024, 12:59 |
Blog
Daniel Michaeli: Excited to share our latest poster from ESMOBreast24 on new breast cancer drugs
Daniel Michaeli, Medical Doctor at National Center for Tumor Diseases (NCT) Heidelberg, shared a post on…
May 16, 2024, 16:51 |
Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
May 13, 2024, 08:24 |
Blog
Monica Bertagnolli: AI Tool Has Promise for Matching Cancer Drugs to Patients
Monica Bertagnolli shared a post on LinkedIn: ''AI Tool Using Single-Cell Data Has Promise for Optimally…
May 5, 2024, 01:02 |
Blog
Amol Akhade: Does this ring bell for other oral drugs also?
Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics, shared a post on X: “Optimal…
May 1, 2024, 11:01 |
Blog
An AI tool to predict cancer response to drugs - NCI Center for Cancer Research
NCI Center for Cancer Research shared a post on LinkedIn: "IN THE NEWS: In case you…
Apr 30, 2024, 13:37 |
Opinion
Wafik El-Deiry: It’s a shame what happens with prescription drugs due to PA requirements
Wafik El-Deiry, Director of Legorreta Cancer Center at Brown University, shared a post on LinkedIn:…
Apr 28, 2024, 16:36 |
Blog
FDA Oncology: OCE's Project Facilitate processed 401 calls and 889 applications for oncology investigational drugs
FDA Oncology shared a post on X: "In 2023, OCE's Project Facilitate handled 401 phone…
Apr 28, 2024, 11:19 |
Blog
Paolo Tarantino: Truly groundbreaking work that turned a failed chemotherapy in one of the most active anticancer drugs ever developed
Paolo Tarantino shared a post by Florian Muller, Co-Head of Biology at Powder Gate Discovery, on…
Apr 26, 2024, 14:15 |
Drugs
Carl Ola Landgren: With Minimal Residual Disease (MRD) as an early endpoint for accelerated approval of new multiple myeloma drugs, patients access to new therapies will be much quicker
Apr 26, 2024, 08:09 |
Blog
Hagop Kantarjian: The results of the first clinical trial to explore activin receptor ligand traps of drugs in MF
Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X: ''Activin receptor…
3
4
5
6
7
All:
827
Posts:
41 - 50
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube